Mucormycosis Causes and Management of Infection-A Review

Authors

  • Bhagat Singh Department of Medical Laboratory Technology, Faculty of Paramedical Sciences, Uttar Pradesh University of Medical Sciences, Saifai Etawah, UP - 206130, India Author

Keywords:

COVID-19, Mucormycosis, Diagnosis, Prophylaxis and treatment

Abstract

Mucormycosis is a disease caused by fungal infection. Its prime target are those persons who are on medication and have reduced immunity to protect their body from secondary infections. Person having lungs infection easily get affected with mucormycosis. Infection occurs through inhalation of spores from air. Recently during COVID-19 in 2019-2022 increasing cases of mucormycosis were observed in survivors. About 45,432 cases of which 4,252 have died have been reported up to 15 July 2021 by states and union territories of India. There are methods for the diagnosis and management of the mucormycosis. Symptoms of Mucormycosis includes redness around eyes and/or nose, pain, fever, coughing headache, shortness of breath, bloody vomits and altered mental status.

Downloads

Download data is not yet available.

References

Downloads

Published

07-07-2025

Issue

Section

Articles

How to Cite

Mucormycosis Causes and Management of Infection-A Review. (2025). International Journal of Medical and Allied Health Sciences, 44-46. https://ijmahs.org/index.php/ijmahs/article/view/1095